FDA approves AI platform for predicting breast cancer risk

The FDA has approved Clarity's AI platform, "Clarity Breast," which predicts a woman's five-year risk of developing breast cancer. Developed by Dr. Connie Leahman, the system analyzes mammograms for subtle patterns linked to future cancer development, offering a risk score for guiding follow-up care. Dr. Eric Winer and Dr. Madhavi Raghu highlight the tool's potential to enhance diagnostic accuracy, despite the irreplaceable value of personal doctor-patient interactions.